<VariationArchive VariationID="1479" VariationName="NM_000190.4(HMBS):c.847_848del (p.Trp283fs)" VariationType="Deletion" Accession="VCV000001479" Version="4" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-03-11" DateCreated="2013-04-04" MostRecentSubmission="2024-03-10">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="16518" VariationID="1479">
      <GeneList>
        <Gene Symbol="HMBS" FullName="hydroxymethylbilane synthase" GeneID="3145" HGNC_ID="HGNC:4982" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NW_009646203.1" start="106480" stop="106757" display_start="106480" display_stop="106757" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="119084881" stop="119093549" display_start="119084881" display_stop="119093549" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="118955586" stop="118964258" display_start="118955586" display_stop="118964258" Strand="+" />
          </Location>
          <OMIM>609806</OMIM>
          <Haploinsufficiency last_evaluated="2020-01-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=HMBS">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-01-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=HMBS">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000190.4(HMBS):c.847_848del (p.Trp283fs)</Name>
      <CanonicalSPDI>NC_000011.10:119092955:TG:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11q23.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="119092956" stop="119092957" display_start="119092956" display_stop="119092957" variantLength="2" positionVCF="119092955" referenceAlleleVCF="CTG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="118963666" stop="118963667" display_start="118963666" display_stop="118963667" variantLength="2" positionVCF="118963665" referenceAlleleVCF="CTG" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>W283fs</ProteinChange>
      <ProteinChange>W226fs</ProteinChange>
      <ProteinChange>W243fs</ProteinChange>
      <ProteinChange>W266fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1076" sequenceAccession="LRG_1076">
            <Expression>LRG_1076:g.13080_13081del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1076t1" sequenceAccession="LRG_1076t1">
            <Expression>LRG_1076t1:c.847_848del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1076p1" sequenceAccession="LRG_1076p1" change="p.Trp283fs">
            <Expression>LRG_1076p1:p.Trp283fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1076t2" sequenceAccession="LRG_1076t2">
            <Expression>LRG_1076t2:c.796_797del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1076p2" sequenceAccession="LRG_1076p2" change="p.Trp266fs">
            <Expression>LRG_1076p2:p.Trp266fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.119092956_119092957del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.119092956_119092957del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001258208.2" sequenceAccession="NM_001258208" sequenceVersion="2" change="c.727_728del">
            <Expression>NM_001258208.2:c.727_728del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001245137.1" sequenceAccession="NP_001245137" sequenceVersion="1" change="p.Trp243fs">
            <Expression>NP_001245137.1:p.Trp243fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001258209.2" sequenceAccession="NM_001258209" sequenceVersion="2" change="c.676_677del">
            <Expression>NM_001258209.2:c.676_677del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001245138.1" sequenceAccession="NP_001245138" sequenceVersion="1" change="p.Trp226fs">
            <Expression>NP_001245138.1:p.Trp226fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.118963666_118963667del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.118963666_118963667del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008093.1" sequenceAccession="NG_008093" sequenceVersion="1" change="g.13080_13081del">
            <Expression>NG_008093.1:g.13080_13081del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000190.4" sequenceAccession="NM_000190" sequenceVersion="4" change="c.847_848del" MANESelect="true">
            <Expression>NM_000190.4:c.847_848del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000181.2" sequenceAccession="NP_000181" sequenceVersion="2" change="p.Trp283fs">
            <Expression>NP_000181.2:p.Trp283fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001024382.2" sequenceAccession="NM_001024382" sequenceVersion="2" change="c.796_797del">
            <Expression>NM_001024382.2:c.796_797del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001019553.1" sequenceAccession="NP_001019553" sequenceVersion="1" change="p.Trp266fs">
            <Expression>NP_001019553.1:p.Trp266fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="609806.0039" DB="OMIM" />
        <XRef Type="rs" ID="1592220835" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="ClinGen" Type="public">ClinGen staff contributed the HGVS expression for this variant.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000190.4(HMBS):c.847_848del (p.Trp283fs) AND Acute intermittent porphyria" Accession="RCV000001544" Version="6">
        <ClassifiedConditionList TraitSetID="387">
          <ClassifiedCondition DB="MedGen" ID="C0162565">Acute intermittent porphyria</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1997-07-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1997-07-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2013-04-04" MostRecentSubmission="2024-03-10">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">9225970</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="387" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4011" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Acute Porphyria</ElementValue>
                <XRef ID="genomeconnect_14819_622" DB="GenomeConnect, ClinGen" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Porphobilinogen deaminase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Uroporphyrinogen synthase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">UPS deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Porphyria, Swedish type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">HMBS deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hydroxymethylbilane Synthase Deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Acute intermittent porphyria</ElementValue>
                <XRef ID="Acute+Intermittent+Porphyria/187" DB="Genetic Alliance" />
                <XRef ID="MONDO:0008294" DB="MONDO" />
                <XRef ID="234422006" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">AIP</ElementValue>
                <XRef Type="MIM" ID="176000" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5732" />
                <XRef ID="5732" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Acute intermittent porphyria (AIP), an autosomal dominant disorder, occurs in heterozygotes for an HMBS pathogenic variant that causes reduced activity of the enzyme porphobilinogen deaminase. AIP is considered "overt" in a heterozygote who was previously or is currently symptomatic; AIP is considered "latent" in a heterozygote who has never had symptoms, and typically has been identified during molecular genetic testing of at-risk family members. Note that GeneReviews does not use the term "carrier" for an individual who is heterozygous for an autosomal dominant pathogenic variant; GeneReviews reserves the term "carrier" for an individual who is heterozygous for an autosomal recessive disorder and thus is not expected to ever develop manifestations of the disorder. Overt AIP is characterized clinically by life-threatening acute neurovisceral attacks of severe abdominal pain without peritoneal signs, often accompanied by nausea, vomiting, tachycardia, and hypertension. Attacks may be complicated by neurologic findings (mental changes, convulsions, and peripheral neuropathy that may progress to respiratory paralysis), and hyponatremia. Acute attacks, which may be provoked by certain drugs, alcoholic beverages, endocrine factors, calorie restriction, stress, and infections, usually resolve within two weeks. Most individuals with AIP have one or a few attacks; about 3%-8% (mainly women) have recurrent attacks (defined as &gt;3 attacks/year) that may persist for years. Other long-term complications are chronic renal failure, hepatocellular carcinoma (HCC), and hypertension. Attacks, which are very rare before puberty, are more common in women than men. Latent AIP. While all individuals heterozygous for an HMBS pathogenic variant that predisposes to AIP are at risk of developing overt AIP, most have latent AIP and never have symptoms.</Attribute>
                <XRef ID="NBK1193" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301372</ID>
                <ID Source="BookShelf">NBK1193</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2007">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_AcuteHepaticPorphyria.pdf</URL>
                <CitationText>Orphanet, Acute hepatic porphyria neuro-visceral crisis, 2007</CitationText>
              </Citation>
              <XRef ID="79276" DB="Orphanet" />
              <XRef ID="C0162565" DB="MedGen" />
              <XRef ID="MONDO:0008294" DB="MONDO" />
              <XRef Type="MIM" ID="176000" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="21699" SubmissionDate="2020-10-31" DateLastUpdated="2024-03-10" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="609806.0039_PORPHYRIA, ACUTE INTERMITTENT" title="HMBS, 2-BP DEL, 847TG_PORPHYRIA, ACUTE INTERMITTENT" />
        <ClinVarAccession Accession="SCV000021699" DateUpdated="2024-03-10" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1997-07-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In affected members of a Swedish family with acute intermittent porphyria (AIP; 176000), Lundin et al. (1997) identified a 2-bp deletion (c.847delTG) in exon 14 of the HMBS gene, resulting in an mRNA translational frameshift.</Attribute>
              <Citation>
                <ID Source="PubMed">9225970</ID>
              </Citation>
              <XRef DB="OMIM" ID="176000" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HMBS" />
          </GeneList>
          <Name>HMBS, 2-BP DEL, 847TG</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DEL, 847TG</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="609806.0039" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PORPHYRIA, ACUTE INTERMITTENT</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="21699" TraitType="Disease" MappingType="Name" MappingValue="PORPHYRIA, ACUTE INTERMITTENT" MappingRef="Preferred">
        <MedGen CUI="C0162565" Name="Acute intermittent porphyria" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

